Project
BREVAS: A Phase 3, multi-center, multinational, randomized, double-blind Study to evaluate the efficacy and safety of Belimumab (HGS1006) in combination with Azathioprine for the maintenance of remission in Wegener’s Granulomatosis and Microscopic Polyangiitis
Completed · 2013 until 2017
Forrer Silvia, Müller Rüdiger
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2013
End Date
2017
Financing
Industry
Keywords
Morbus Wegener, Belimumab, Granulomatose
Brief description/objective
Belimumab bei Patienten mit Wegener Granulomatose nach Induktion mit Rituximab und Prednison